Oncothyreon Announces Presentations at Upcoming Investment Conferences in September 2012
SEATTLE, Aug. 29, 2012 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) announced today that Robert Kirkman, M.D., President and Chief Executive Officer, will be presenting at the following upcoming investment conferences in September.
Stifel Nicolaus 2012 Annual Healthcare Conference
Wednesday, September 5, 2012, at 3:15 p.m. Eastern time in Boston, MA
Rodman & Renshaw 14th Annual Healthcare Conference
Tuesday, September 11, 2012, at 10 a.m. Eastern time in New York, NY
A live and archived webcast of each presentation will be accessible by visiting the Oncothyreon website www.oncothyreon.com under the "News & Events" section.
Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit www.oncothyreon.com.
SOURCE Oncothyreon Inc.